Literature DB >> 11030275

Nasal polyposis: clinical course during 20 years.

S I Vento1, L O Ertama, M L Hytönen, C H Wolff, C H Malmberg.   

Abstract

BACKGROUND: The etiology of nasal polyposis is mainly unknown although it has been connected with many clinical conditions. The long-term clinical course of nasal polyposis is largely unknown, because long-term followup studies on the recurrence of nasal polyposis have rarely been reported.
OBJECTIVE: The aim of the study was to find out the clinical course of nasal polyposis over a long period of time. PATIENTS AND METHODS: Our report describes a 20-year follow-up study of 41 patients with nasal polyps. These patients had surgery for nasal polyp disease 20 years previously and they were initially grouped according to occurrence of (1) acetylsalicylic acid (ASA) intolerance, (2) atopic allergy (AT), and (3) intrinsic allergy-like disease (INTR). Patients were now re-examined, sinus computed tomography (CT) scanning was made, and a biopsy from polyp or from mucosa of the middle turbinate was taken.
RESULTS: Anterior rhinoscopy revealed polyps in 35 of 41 patients. Thus nasal polyposis was still active in 85% of patients after 20 years. Mucosal changes in paranasal sinuses were found in every patient. Anosmia or hyposmia was found in 61% (25/41) of the patients. Eight patients had had 11 or more surgical operations during the 20-year period. Of these, 88% (7/8) belonged to the ASA group. Bronchial asthma was found in all ASA intolerance patients (11/11), and in 36% (4/11) of AT and in 16% (3/19) of INTR patients, respectively.
CONCLUSION: Because of the high recurrence tendency and insidious symptoms of nasal polyposis, patients will require followup for the rest of their lives.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11030275     DOI: 10.1016/S1081-1206(10)62468-4

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  18 in total

Review 1.  Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis.

Authors:  Mauricio López-Chacón; Joaquim Mullol; Laura Pujols
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

2.  Prospective evaluation of oral corticosteroid as a predictor of postoperative olfactory recovery after functional endoscopic surgery for nasal polyposis.

Authors:  Pauline Rives; Florent Espitalier; Guillaume Michel; Xavier Blanc; Cyrille Fortun; Olivier Malard
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-03       Impact factor: 2.503

3.  The treatment efficacy of nasal polyposis on olfactory functions, clinical scoring systems and inflammation markers.

Authors:  Zehra Betul Paksoy; Melih Cayonu; Cigdem Yucel; Turan Turhan
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-31       Impact factor: 2.503

4.  Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad.

Authors:  Miriam Havel; Lena Ertl; Franziska Braunschweig; Sabine Markmann; Andreas Leunig; Fernando Gamarra; Matthias F Kramer
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-18       Impact factor: 2.503

Review 5.  Natural history and clinical features of aspirin-exacerbated respiratory disease.

Authors:  John M Fahrenholz
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

6.  Availability of preoperative systemic steroids on endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis.

Authors:  Seok Jin Hong; Jong Kyu Lee; Hyun Sub Lee; Jung Yup Lee; Jung Soo Pyo; Kyung Chul Lee
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

Review 7.  Pharmacological management of nasal polyposis.

Authors:  Claus Bachert; Jean-Baptiste Watelet; Philippe Gevaert; Paul Van Cauwenberge
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  The influence of bacterial biofilm on the clinical outcome of chronic rhinosinusitis: a prospective, double-blind, scanning electron microscopy study.

Authors:  Roman Głowacki; Krzysztof A Tomaszewski; Paweł Stręk; Iwona M Tomaszewska; Katarzyna Zgórska-Świerzy; Beata Markiewicz; Jacek Składzień
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-18       Impact factor: 2.503

9.  Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease.

Authors:  Katherine N Cahill; Benjamin A Raby; Xiaobo Zhou; Feng Guo; Derek Thibault; Andreas Baccarelli; Hyang-Min Byun; Neil Bhattacharyya; John W Steinke; Joshua A Boyce; Tanya M Laidlaw
Journal:  Am J Respir Cell Mol Biol       Date:  2016-01       Impact factor: 6.914

10.  Relationships between IL-17A and macrophages or MUC5AC in eosinophilic chronic rhinosinusitis and proposed pathological significance.

Authors:  Noritsugu Ono; Takeshi Kusunoki; Katsuhisa Ikeda
Journal:  Allergy Rhinol (Providence)       Date:  2012-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.